Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Special Article: Advanced therapy medicinal products in Brazil: regulatory panorama

Advanced therapy medicinal products, considered special medications, requires Anvisa approval for use and commercialization in Brazil. They include the advanced cellular therapy products, tissue engineering products and gene therapy products, which due to their complexity involve innovation and risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva Junior, João Batista, Rodrigues e Silva, Antonio Alfredo, Melo, Francielli Cristine Cunha, Kumoto, Melina Cossote, Parca, Renata Miranda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606716/
https://www.ncbi.nlm.nih.gov/pubmed/34794800
http://dx.doi.org/10.1016/j.htct.2021.09.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606716/
https://www.ncbi.nlm.nih.gov/pubmed/34794800
http://dx.doi.org/10.1016/j.htct.2021.09.010

Ejemplares similares